Recombinant LipL32 protein developed using a synthetic gene detects leptospira-specific antibodies in human serum samples

Background: Synthetic biology is emerging as a viable alternative for the production of recombinant antigens for diagnostic applications. It offers a safe alternative for the synthesis of antigenic principles derived from organisms that pose a high biological risk. Methods: Here, we describe an enzy...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuszniahyati Yaakob, Kenneth Francis Rodrigues, Fernandes Opook, Timothy William, Daisy Vanitha John
Format: Article
Language:English
English
Published: Universiti Sains Malaysia 2017
Subjects:
Online Access:https://eprints.ums.edu.my/id/eprint/30245/1/Recombinant%20LipL32%20protein%20developed%20using%20a%20synthetic%20gene%20detects%20leptospira-specific%20antibodies%20in%20human%20serum%20samples%20ABSTRACT.pdf
https://eprints.ums.edu.my/id/eprint/30245/2/Recombinant%20LipL32%20protein%20developed%20using%20a%20synthetic%20gene%20detects%20leptospira-specific%20antibodies%20in%20human%20serum%20samples%20FULL%20TEXT.pdf
https://eprints.ums.edu.my/id/eprint/30245/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772814/pdf/05mjms24052017_oa3.pdf
https://doi.org/10.21315/mjms2017.24.5.5
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Synthetic biology is emerging as a viable alternative for the production of recombinant antigens for diagnostic applications. It offers a safe alternative for the synthesis of antigenic principles derived from organisms that pose a high biological risk. Methods: Here, we describe an enzyme-linked immunosorbent assay (ELISA) using the synthetic recombinant LipL32 (rLipL32) protein expressed in Escherichia coli for the detection of Leptospira-specific antibodies in human serum samples. The rLipL32-based ELISA was compared with a microscopic agglutination test (MAT), which is currently used as the gold standard for the diagnosis of leptospirosis. Results: Our results showed that all the MAT-positive serum samples were positive for Leptospira-specific IgG in an ELISA, while 65% (n = 13) of these samples were also positive for Leptospira-specific IgM. In the MAT-negative serum samples, 80% and 55% of the samples were detected as negative by an ELISA for Leptospira-specific IgM and IgG, respectively. Conclusion: An ELISA using the synthetic rLipL32 antigen was able to distinguish Leptospira-specific IgM (sensitivity 65% and specificity 80%) and IgG (sensitivity 100% and specificity 55%) in human serum samples and has the potential to serve as a rapid diagnostic test for leptospirosis.